May 21, 2021 10:41 AM EDT
Coronavirus

Covid-19 roundup: Mod­er­na's jab gains ap­proval in Japan and South Ko­rea; J&J and Gavi reach agree­ment for 200M more dos­es

Josh Sullivan

While Japan is ex­pe­ri­enc­ing its worst spike in Covid-19 deaths since ear­ly Feb­ru­ary, its min­istry of health has ap­proved Mod­er­na’s Covid-19 vac­cine for use. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times